Boston-based Valo Health, a company that analyzes clinical data to identify molecules and predict their drug usage chances, raises $300M series B. The company focuses its effort into improving the way drugs are brought into the market. Making it safer for anyone who needs to consume them.
You can read the full story here. (Daniel McCoy/Wichita Business Journal)
